Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 8;9(2):247.
doi: 10.1097/j.pbj.0000000000000247. eCollection 2024 Mar-Apr.

Prognostic impact of thrombocytosis in gastric cancer-A retrospective study

Affiliations

Prognostic impact of thrombocytosis in gastric cancer-A retrospective study

Bárbara Neto Castro et al. Porto Biomed J. .

Abstract

Background: Solid tumors are a common cause of secondary thrombocytosis, which has been identified as a prognostic factor in various cancers. However, the impact of thrombocytosis on the prognosis of gastric cancer is not yet well defined. The aim of this study was to assess the prevalence and prognostic value of thrombocytosis in patients with gastric cancer.

Methods: This was a retrospective study of patients with gastric carcinoma treated surgically, with curative intent, in our hospital, Centro Hospitalar Vila Nova de Gaia/Espinho, between January 2009 and December 2019. Clinical files were consulted and clinicopathological characteristics were analyzed.

Results: In the present sample (n = 352), the prevalence of pretreatment thrombocytosis was 16.5%. Thrombocytosis was associated with more advanced T stage, greater number of metastatic nodes, and more frequent lymphatic and venous permeation. The presence of thrombocytosis had a negative impact on disease-free survival (hazard ratio [HR] 3.54, 95% confidence interval [CI] 2.35-5.33, P < .001) and overall survival (HR 4.45, 95% CI 2.95-6.71, P < .001).

Conclusions: The presence of pretreatment thrombocytosis had a negative impact on overall survival and disease-free survival and thus could be used as an independent prognostic factor.

Keywords: gastric cancer; thrombocytosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1.
Figure 1.
Impact of thrombocytosis on disease-free survival of patients with gastric cancer.
Figure 2.
Figure 2.
Impact of thrombocytosis on overall survival of patients with gastric cancer.

Similar articles

References

    1. Yang C, Jiang H, Huang S, et al. . The prognostic role of pretreatment thrombocytosis in gastric cancer: a systematic review and meta-analysis. Medicine. 2018;97(31):e11763. - PMC - PubMed
    1. Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187–203. - PMC - PubMed
    1. Oh SE, Seo JE, An JY, et al. . Prognostic impact of increased perioperative platelet count in gastric cancer patients. J Surg Res. 2019;242:296–303. - PubMed
    1. Baranyai Z, Jósa V, Tóth A, et al. . Paraneoplastic thrombocytosis in gastrointestinal cancer. Platelets. 2016;27(4):269–75. - PubMed
    1. Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interaction in solid tumors. Int J Cancer. 2012;130(12):2747–60. - PubMed